Mutational and haplotype analysis of AGL in patients with glycogen storage disease type III

被引:21
作者
Horinishi, A
Okubo, M
Tang, NLS
Hui, J
To, KF
Mabuchi, T
Okada, T
Mabuchi, H
Murase, T
机构
[1] Okinaka Mem Inst Med Res, Dept Endocrinol & Metab, Minato Ku, Tokyo 1058470, Japan
[2] Toranomon Gen Hosp, Minato Ku, Tokyo 1058470, Japan
[3] Chinese Univ Hong Kong, Dept Chem Pathol, Fac Med, Hong Kong, Hong Kong, Peoples R China
[4] Chinese Univ Hong Kong, Dept Pediat, Fac Med, Hong Kong, Hong Kong, Peoples R China
[5] Kanazawa Univ, Sch Med, Dept Internal Med 2, Kanazawa, Ishikawa 920, Japan
关键词
glycogen storage disease type III; glycogen-debranching enzyme; AGL; nonsense mutation; splicing; haplotype; recurrent mutation;
D O I
10.1007/s100380200000
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Glycogen storage disease type III (GSD III) is a rare autosomal recessive inherited disorder caused by a deficiency of the glycogen-debranching enzyme (AGL). We investigated two GSD III patients and identified four different mutations. Nucleotide sequence analysis revealed patient 1 of Chinese descent to be a compound heterozygote for a novel nonsense mutation, R34X, and the splicing mutation (IVS32-12A > G) reported in a Japanese patient. Patient 2 of Japanese origin was found to be compound heterozygous for a novel nonsense mutation, Y1148X, and the splicing mutation (IVS14+1G > T) that we had described previously. To determine whether splicing mutations occurred independently, we performed intense AGL haplotype analysis using 21 intragenic polymorphic markers plus a novel polymorphism IVS32 - 97 A/G in the vicinity of the IVS32 splicing mutation. Patient 1 of Chinese origin and the Japanese patient homozygous for the IVS32 - 12A > G were found to have different haplotypes, indicating the IVS32 - 12A > G mutation to be a recurrent mutation. This is the first recurrent mutation established by intense haplotyping in the AGL gene.
引用
收藏
页码:55 / 59
页数:5
相关论文
共 50 条
  • [41] Glycogen storage disease type III-hepatocellular carcinoma a long-term complication?
    Demo, Erin
    Frush, Donald
    Gottfried, Marcia
    Koepke, John
    Boney, Anne
    Bali, Deeksha
    Chen, Y. T.
    Kishnani, Priya S.
    JOURNAL OF HEPATOLOGY, 2007, 46 (03) : 492 - 498
  • [42] High frequency of W1327X mutation in glycogen storage disease type III patients from central Tunisia
    Cherif, Wafa
    Ben Rhouma, Faten
    Messai, Habib
    Mili, Amira
    Gribaa, Moez
    Kefi, Rym
    Ayadi, Abdelkarim
    Boughamoura, Lamia
    Chemli, Jelel
    Saad, Ali
    Kaabachi, Naziha
    Sfar, Mohamed Tahar
    Ben Dridi, Marie-Francoise
    Tebib, Neji
    Abdelhak, Sonia
    ANNALES DE BIOLOGIE CLINIQUE, 2012, 70 (06) : 648 - 650
  • [43] GLYCOGEN-STORAGE-DISEASE TYPE-III (GLYCOGEN DEBRANCHING ENZYME DEFICIENCY) - CORRELATION OF BIOCHEMICAL DEFECTS WITH MYOPATHY AND CARDIOMYOPATHY
    COLEMAN, RA
    WINTER, HS
    WOLF, B
    GILCHRIST, JM
    CHEN, YT
    ANNALS OF INTERNAL MEDICINE, 1992, 116 (11) : 896 - 900
  • [44] Uniparental isodisomy of chromosome 1 results in glycogen storage disease type III with profound growth retardation
    Ponzi, Emanuela
    Alesi, Viola
    Lepri, Francesca R.
    Genovese, Silvia
    Loddo, Sara
    Mucciolo, Mafalda
    Novelli, Antonio
    Dionisi-Vici, Carlo
    Maiorana, Arianna
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2019, 7 (05):
  • [45] Case Report: Rupture of a gastric varix in liver cirrhosis associated with glycogen storage disease type III
    Hashimoto, M
    Watanabe, G
    Yokoyama, T
    Tsutsumi, K
    Dohi, T
    Matsuda, M
    Okubo, M
    Nakamura, N
    Tsurumaru, M
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1998, 13 (02) : 232 - 235
  • [46] Whole-Body Muscle Magnetic Resonance Imaging in Glycogen-Storage Disease Type III
    Tobaly, David
    Laforet, Pascal
    Perry, Ariane
    Habes, Dalila
    Labrune, Philippe
    Decostre, Valerie
    Masingue, Marion
    Petit, Francois
    Barp, Andrea
    Bello, Luca
    Carlier, Pierre
    Carlier, Robert-Yves
    MUSCLE & NERVE, 2019, 60 (01) : 72 - 79
  • [47] Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle
    Shen, JJ
    Bao, Y
    Liu, HM
    Lee, P
    Leonard, JV
    Chen, YT
    JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (02) : 352 - 357
  • [48] Glucose-free/high-protein diet improves hepatomegaly and exercise intolerance in glycogen storage disease type III mice
    Pagliarani, Serena
    Lucchiari, Sabrina
    Ulzi, Gianna
    Ripolone, Michela
    Violano, Raffaella
    Fortunato, Francesco
    Bordoni, Andreina
    Corti, Stefania
    Moggio, Maurizio
    Bresolin, Nereo
    Comi, Giacomo P.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2018, 1864 (10): : 3407 - 3417
  • [49] Long term longitudinal study of muscle function in patients with glycogen storage disease type IIIa
    Decostre, Valerie
    Laforet, Pascal
    De Antonio, Marie
    Kachetel, Kahina
    Canal, Aurelie
    Ollivier, Gwenn
    Nadaj-Pakleza, Aleksandra
    Petit, Francois M.
    Wahbi, Karim
    Fayssoil, Abdallah
    Eymard, Bruno
    Behin, Anthony
    Labrune, Philippe
    Hogrel, Jean-Yves
    MOLECULAR GENETICS AND METABOLISM, 2017, 122 (03) : 108 - 116
  • [50] Evaluation of a fluorimetric for determining the activity of amylo-1,6-glucosidase in leukocytes for confirming the diagnosis of glycogen storage disease type III
    Miadi-Messaoud, Hanene
    Mili, Amira
    Ben Khalifa, Hammadi
    Limem, Khalifa
    ANNALES DE BIOLOGIE CLINIQUE, 2011, 69 (01) : 41 - 45